“Resorbable Orthopedics has patented technologies that include a resorbable bone wax and a delivery system for orthopedic bone void fillers that were previously unheard of. Orthopedic disorders are expanding internationally into a multi-billion dollar market,” Barry Constantine, founder of Resorbable Orthopedics, said in the release. “Market entry is expected in third quarter 2010 subject to initiation and completion of certain medical certifications.”
Wound Management Technologies has spent the last year focusing on distribution of its CellerateRx product, according to the release.
Read the release about Resorbable Orthopedics.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
